Recap: Amphastar Pharma Q3 Earnings
Portfolio Pulse from Benzinga Insights
Amphastar Pharma (NASDAQ:AMPH) reported its Q3 earnings, beating estimated earnings by 66.67% with an EPS of $1.15 versus an estimate of $0.69. Revenue was up $60.43 million from the same period last year. Last quarter, the company beat on EPS by $0.09, which was followed by a 4.29% drop in the share price the next day.
November 08, 2023 | 9:35 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Amphastar Pharma's Q3 earnings beat estimates, with an EPS of $1.15, a 66.67% increase. However, past performance shows a share price drop following an earnings beat.
While Amphastar Pharma's Q3 earnings beat is a positive sign, the company's share price has previously dropped following an earnings beat. This suggests that while the company's financial performance is strong, market reactions may not necessarily reflect this in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100